526 related articles for article (PubMed ID: 25751168)
1. Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
Su Y; Hu Y; Du Y; Huang X; He J; You J; Yuan H; Hu F
Mol Pharm; 2015 Apr; 12(4):1193-202. PubMed ID: 25751168
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
Hu FQ; Liu LN; Du YZ; Yuan H
Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
Hu FQ; Wu XL; Du YZ; You J; Yuan H
Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cytotoxicity of core modified chitosan based polymeric micelles for doxorubicin delivery.
Ye YQ; Chen FY; Wu QA; Hu FQ; Du YZ; Yuan H; Yu HY
J Pharm Sci; 2009 Feb; 98(2):704-12. PubMed ID: 18563810
[TBL] [Abstract][Full Text] [Related]
5. Linoleic acid-grafted chitosan oligosaccharide micelles for intracellular drug delivery and reverse drug resistance of tumor cells.
Du YZ; Wang L; Yuan H; Hu FQ
Int J Biol Macromol; 2011 Jan; 48(1):215-22. PubMed ID: 21093477
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of lamivudine stearate and antiviral activity of stearic acid-g-chitosan oligosaccharide polymeric micelles delivery system.
Li Q; Du YZ; Yuan H; Zhang XG; Miao J; Cui FD; Hu FQ
Eur J Pharm Sci; 2010 Nov; 41(3-4):498-507. PubMed ID: 20728535
[TBL] [Abstract][Full Text] [Related]
7. Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance.
Meng T; Lu B; Shao S; Yuan M; Liu X; Yuan H; Huang X; Hu F
Int J Pharm; 2017 Dec; 534(1-2):368-377. PubMed ID: 29051118
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and characterization of stearic acid-grafted chitosan oligosaccharide polymeric micelles].
Ye YQ; Hu FQ; Yuan H
Yao Xue Xue Bao; 2004 Jun; 39(6):467-71. PubMed ID: 15491108
[TBL] [Abstract][Full Text] [Related]
9. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cellular uptake of chlorine e6 mediated by stearic acid-grafted chitosan oligosaccharide micelles.
Hu FQ; Jiang XH; Huang X; Wu XL; Yuan H; Wei XH; Du YZ
J Drug Target; 2009 Jun; 17(5):384-91. PubMed ID: 19343607
[TBL] [Abstract][Full Text] [Related]
11. Selective redox-responsive drug release in tumor cells mediated by chitosan based glycolipid-like nanocarrier.
Hu YW; Du YZ; Liu N; Liu X; Meng TT; Cheng BL; He JB; You J; Yuan H; Hu FQ
J Control Release; 2015 May; 206():91-100. PubMed ID: 25796347
[TBL] [Abstract][Full Text] [Related]
12. In vitro antitumour activity of stearic acid-g-chitosan oligosaccharide polymeric micelles loading podophyllotoxin.
Huang X; Huang X; Jiang XH; Hu FQ; Du YZ; Zhu QF; Jin CS
J Microencapsul; 2012; 29(1):1-8. PubMed ID: 22229874
[TBL] [Abstract][Full Text] [Related]
13. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies.
Hu FQ; Zhao MD; Yuan H; You J; Du YZ; Zeng S
Int J Pharm; 2006 Jun; 315(1-2):158-66. PubMed ID: 16632285
[TBL] [Abstract][Full Text] [Related]
14. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY
Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336
[TBL] [Abstract][Full Text] [Related]
15. PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy.
Hu FQ; Meng P; Dai YQ; Du YZ; You J; Wei XH; Yuan H
Eur J Pharm Biopharm; 2008 Nov; 70(3):749-57. PubMed ID: 18620050
[TBL] [Abstract][Full Text] [Related]
16. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
Hu FQ; Zhang YY; You J; Yuan H; Du YZ
Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
[TBL] [Abstract][Full Text] [Related]
17. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP
Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890
[TBL] [Abstract][Full Text] [Related]
18. Stearic acid grafted chitosan oligosaccharide micelle as a promising vector for gene delivery system: factors affecting the complexation.
Du YZ; Lu P; Zhou JP; Yuan H; Hu FQ
Int J Pharm; 2010 May; 391(1-2):260-6. PubMed ID: 20170716
[TBL] [Abstract][Full Text] [Related]
19. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
[TBL] [Abstract][Full Text] [Related]
20. Improved cytotoxicity and multidrug resistance reversal of chitosan based polymeric micelles encapsulating oxaliplatin.
Xu YY; Du YZ; Yuan H; Liu LN; Niu YP; Hu FQ
J Drug Target; 2011 Jun; 19(5):344-53. PubMed ID: 20854014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
